PDF Cover

Transcranial Magnetic Stimulation System Market

Transcranial Magnetic Stimulation System Market

The market for Transcranial Magnetic Stimulation System was estimated at $2.4 billion in 2024; it is anticipated to increase to $4.0 billion by 2030, with projections indicating growth to around $6.2 billion by 2035.

Report ID:DS1801224
Author:Debadatta Patel - Senior Consultant
Published Date:June 2025
Datatree
Transcranial Magnetic Stimulation System
Share
Report Summary
Table of Contents
Methodology
Market Data

Global Transcranial Magnetic Stimulation System Market Outlook

Revenue, 2024

$2.4B

Forecast, 2034

$5.7B

CAGR, 2024 - 2034

9.1%
The Transcranial Magnetic Stimulation System industry revenue is expected to be around $2.6 billion in 2025 and expected to showcase growth with 9.1% CAGR between 2025 and 2034. Investments in the advancement of Transcranial Magnetic Stimulation technology showcase its rising significance in the healthcare sector. The growing need is mainly driven by the occurrence of brain related conditions the increase in elderly individuals and the preference shift towards non invasive therapies over invasive treatments. The progress in technology greatly contributes to driving this expansion making TMS systems indispensable, in healthcare approaches.

Transcranial Magnetic Stimulation Systems are cutting edge tools made to send pulses through the complex network of the human brain without the need for surgery by utilizing electro magnetism principles to stimulate specific brain areas effectively for various purposes like addressing mental health issues such, as depression and anxiety and aiding in stroke recovery efforts.

Transcranial Magnetic Stimulation System market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034

Market Key Insights

  • The Transcranial Magnetic Stimulation System market is projected to grow from $2.4 billion in 2024 to $5.7 billion in 2034. This represents a CAGR of 9.1%, reflecting rising demand across Therapy for Clinical Depression, Migraine Therapy and Research in Neuroplasticity.
  • MagVenture Inc., Neurosoft Ltd., Brainsway Ltd. are among the leading players in this market, shaping its competitive landscape.
  • U.S. and Germany are the top markets within the Transcranial Magnetic Stimulation System market and are expected to observe the growth CAGR of 6.6% to 9.6% between 2024 and 2030.
  • Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 8.7% to 11.4%.
  • Transition like Emergence of Personalized Medicine is expected to add $400.0 million to the Transcranial Magnetic Stimulation System market growth by 2030
  • The Transcranial Magnetic Stimulation System market is set to add $3.3 billion between 2024 and 2034, with manufacturer targeting Ambulatory Surgical Centers & Psychological Therapy Centers End-Users projected to gain a larger market share.
  • With Rising prevalence of mental health disorders, and Technological advancements in neurology, Transcranial Magnetic Stimulation System market to expand 139% between 2024 and 2034.
transcranial magnetic stimulation system market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the Transcranial Magnetic Stimulation System

Collaborating closely with known research institutions and medical entities and overcoming regulatory obstacles can lead to significant benefits, in the field of Transcranial Magnetic Stimulation Systems innovation and market expansion.

Growth Opportunities in North America and Asia Pacific

North America Outlook

North America is considered a market for Transcranial Magnetic Stimulation Systems due to its strong healthcare system that influences the need for cutting edge neurological treatments significantly. The rising awareness of health conditions and the growing elderly population are driving forces fueling the demand for Transcranial Magnetic Stimulation Systems in this region. There is competition in the region with many well known companies providing advanced technologies, in Transcranial Magnetic Stimulation Systems. The main possibilities involve creating affordable Transcranial Magnetic Stimulation Systems and broadening their use to address different neurological conditions.

Asia Pacific Outlook

The Transcranial Magnetic Stimulation System sector is booming in the Asia Pacific region with urbanization and a growing focus on health and better access to healthcare driving the demand up significantly. The presence of both manufacturers and global giants is making the market more diverse in this region amidst increasing competition. There are potential opportunities, for improving Transcranial Magnetic Stimulation System technologies to make them more user friendly and effective here. The main factor guiding this region is the increased prevalence of health concerns and the expanding approval of sophisticated treatment approaches, among the community.

Market Dynamics and Supply Chain

01

Driver: Rising Prevalence of Mental Health Disorders, and Broadening Scope of Clinical Applications

The rise of health issues globally like depression and anxiety has also a significant impact on the market for Transcranial Magnetic Stimulation Systems. The treatment resistant nature of many of these disorders highlights the need for advanced therapies such as transcranial magnetic stimulation. This procedure targets brain regions without invasive methods and has also led to an increased demand, for these systems to effectively address mental health conditions. The increasing use of the Transcranial Magnetic Stimulation System in treating medical conditions like Alzheimers disease or stroke is also leading to a higher requirement, for adaptable and efficient resonance focused treatments.
The field of magnetic stimulation has also seen notable progress alongside the growing prevalence of mental health conditions. This progress is also driven by innovations like digitalized monitoring and mapping systems and enhanced coil designs that incorporate advanced stimulation techniques. These developments are also enhancing the effectiveness and flexibility of magnetic stimulation devices enabling the customization of treatment approaches and contributing to the expansion of the global market, for transcranial magnetic stimulation therapies.
02

Restraint: High Costs of Transcranial Magnetic Stimulation Systems

The sophisticated technology employed in Transcranial Magnetic Stimulation Systems results in them being quite expensive by nature. This could pose a challenge, for numerous individuals and healthcare institutions worldwide. In less affluent areas where financial limitations are prominent the substantial expenses associated with purchasing, maintaining and operating these systems may put a damper on demand. Despite the advantages they offer the exorbitant cost continues to be a hurdle that could hinder the expansion of the market.
03

Opportunity: Untapped Market Segments and Technological Innovation

The Transcranial Magnetic Stimulation Systems market has room for growth by reaching out to areas that are not only well served by existing solutions such as patients with treatment resistant depression and PTSD as well as specific neurological conditions who stand to gain significantly from this innovative technologys advancements in personalized care strategies that could spur notable market expansion opportunities at the intersection of neurology, psychiatry and digital health leading to a more holistic approach, to patient care.
The ongoing advancements in intelligence and ML present a promising opportunity to incorporate these innovations into Transcranial Magnetic Stimulation Systems . By leveraging these advancements in TMS systems can lead to tailored and improved treatment strategies that enhance patient results significantly and simplify operational procedures to create a more user friendly experience, for patients.
04

Challenge: Lack of Skilled Professionals

One issue lies in the scarcity of experts with the skills to operate Transcranial Magnetic Stimulation Systems proficiently and securely. These advanced systems demand training, for effective and safe operation. As a result of the number of such professionals available the distribution and acceptance of these systems may be impeded, which could impact market trends and demand. The sector needs to prioritize programs and enhancing the skills of healthcare workers to overcome this possible obstacle.

Supply Chain Landscape

1
Component Production

Siemens

Philips Healthcare

2
Manufacturing & Assembly

Neuronetics

Magstim Group

3
Distribution & Supply

Mectronic Medicale

S.p.A

Neurosoft

4
End Use

Healthcare Institutions

Neurological Research Centers

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of Transcranial Magnetic Stimulation System in Therapy for Clinical Depression, Migraine Therapy & Research in Neuroplasticity

Therapy for Clinical Depression
Transcranial Magnetic Stimulation Systems have shown success in treating clinical depression and are widely used in mental health facilities worldwide. They have become well established in healthcare institutions as they provide safe and non invasive therapy options. One notable player in this field is NeuroStar with its TMS Therapy system that has demonstrated positive outcomes for patients, with treatment resistant depression.
Migraine Therapy
Transcranial Magnetic Stimulation Systems have been extensively used in neurology to treat migraines well. Modern systems such as eNeuras user friendly system deliver magnetic pulses to alleviate migraines by interfering with the neural activity responsible, for them.
Research in Neuroplasticity
Transcranial Magnetic Stimulation Systems play a role not only in the medical sector but also in neurological research focused primarily on neuroplasticity studies. Magstim stands out as a player in this field by providing advanced equipment that targets specific brain region's with precision and safety. This technology aids scientists in delving into how the brain can transform and adjust itself while exploring its impact, on learning and memory functions.

Recent Developments

December 2024
NeuroStars advanced TMS Therapy has been approved by the FDA for treating depressive disorder in teenagers using their Transcranial Magnetic Stimulation Systems.
October 2024
BrainsWay been greenlit for its Deep TMS platform which provides clinicians, with an effective option compared to traditional electrically based transcranial magnetic stimulation systems.
August 2024
MagVenture introduced its portable device to the market to make Transcranial Magnetic Stimulation Therapy more accessible, in remote areas.
The Transcranial Magnetic Stimulation System is making progress every day and changing the face of contemporary healthcare practices. The innovative system uses induction to target specific areas of the brain for treating a range of neurological and psychiatric disorders. Naturally TMS has been a player in cutting edge neurological studies demonstrating its vast possibilities within the mental health field and, beyond.

Impact of Industry Transitions on the Transcranial Magnetic Stimulation System Market

As a core segment of the Medical Device industry, the Transcranial Magnetic Stimulation System market develops in line with broader industry shifts. Over recent years, transitions such as Emergence of Personalized Medicine and Technological advancements in delivery have redefined priorities across the Medical Device sector, influencing how the Transcranial Magnetic Stimulation System market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Emergence of Personalized Medicine

Advancements in the field of medicine have led to the incorporation of magnetic stimulation systems, in personalized healthcare strategies. This evolution enables customizing treatment approaches to meet patient needs by considering their genetic traits, biomarkers, physical attributes and social factors. Challenging the approach by customizing solutions has proven successful in fields such, as neurology and psychiatry; it has advanced our comprehension of mental health conditions and treatment methods using transcranial magnetic stimulation technology to enhance patient care significantly. This industry transition is expected to add $400 million in the industry revenue between 2024 and 2030.
02

Technological advancements in delivery

The field of magnetic stimulation technology has seen notable advancements in how this treatment is administered over time. Initially used primarily in settings. the technology has now evolved to encompass home based devices as well. This shift has had an impact on sectors, like home healthcare and telemedicine. offering improved avenues for patients to receive treatment and monitoring services.

Related Reports

Loading related reports...